Zivo Bioscience, Inc. (ZIVOW) — 10-Q Filings
All 10-Q filings from Zivo Bioscience, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Zivo Bioscience Narrows Losses, Cash Dwindles Amid R&D Spend
— Nov 14, 2025 Risk: high
Zivo Bioscience, Inc. (ZIVOW) reported a net loss of $1,033,056 for the three months ended September 30, 2025, a significant improvement from the $2,268,597 net -
Zivo Bioscience Narrows Losses Amidst Cash Crunch, Strategic Shifts
— Aug 14, 2025 Risk: high
Zivo Bioscience, Inc. reported a net loss of $1,640,232 for the three months ended June 30, 2025, a significant improvement from the $8,236,368 net loss in the -
Zivo Bioscience Q1 Revenue Plummets, Expenses Cut
— May 15, 2025 Risk: high
Zivo Bioscience, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported $0.001 million in revenue for Q1 2025, compared to $3.62 million -
Zivo Bioscience Reports Q3 Loss, Completes Private Placements
— Nov 14, 2024 Risk: medium
Zivo Bioscience, Inc. filed its Q3 2024 10-Q report on November 14, 2024, covering the period ending September 30, 2024. The company reported a net loss of $3,4 -
Zivo Bioscience Q2 2024: No Revenue, Net Loss
— Aug 14, 2024 Risk: high
Zivo Bioscience, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported no revenue for the quarter and a net loss. Subsequent events incl -
Zivo Bioscience Files 10-Q for Q1 2024
— May 13, 2024 Risk: medium
Zivo Bioscience, Inc. (ZIVOW) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Zivo Bioscience reported $278,965 in revenue for Q1 2024, a signific
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX